What are the distinguishing clinical, radiographic, and histopathologic features of Burkitt lymphoma versus ameloblastoma in the mandible of a 14‑year‑old girl?

Distinguishing Burkitt Lymphoma from Ameloblastoma in the Mandible of a 14-Year-Old Girl

In a 14-year-old girl with a mandibular lesion, Burkitt lymphoma should be strongly suspected over ameloblastoma if there is rapid progression (days to weeks), tooth mobility, loss of lamina dura on radiographs, systemic symptoms, and extremely high Ki-67 proliferation index (≥95%), whereas ameloblastoma presents with slow growth (months to years), well-demarcated unilocular or multilocular radiolucency, and no systemic involvement.

Clinical Presentation

Burkitt Lymphoma

• Rapid onset and progression: Symptoms develop over days to weeks 1
• Jaw involvement: Swelling in the jaw, gingival area, or maxilla 2
• Tooth mobility: Severely mobile or displaced teeth are characteristic 1, 3
• Systemic symptoms: Fever, night sweats, weight loss, generalized lymphadenopathy (submandibular, cervical, axillary, inguinal) 2, 3
• Age: Peak incidence in pediatric population, highly relevant for a 14-year-old 2
• Potential oncologic emergencies: Tumor lysis syndrome, respiratory compromise, or spinal cord compression due to rapid tumor growth 2

Ameloblastoma

• Slow, insidious growth: Develops over months to years 4
• Painless swelling: Most common presenting symptom (38% of cases) 4
• Teeth typically stable: Unless very advanced disease
• No systemic symptoms: Purely local disease without fever, weight loss, or lymphadenopathy
• Age: Mean age 30.4 years, though can occur in adolescents (range 11-70 years) 4

Radiographic Features

Burkitt Lymphoma

• Rapid bone destruction: Radiographic changes visible within 17 days showing progressive alveolar bone destruction 1
• Loss of lamina dura: Effacement of dental lamina dura occurs in 91% of jaw-confined tumors and 72.7% of abdominal tumors 5
• Periapical bone resorption: Without clinically detectable jaw tumors initially 1
• Ill-defined, destructive pattern: Aggressive bone destruction with poorly defined margins
• Alveolar bone crest destruction: Affecting multiple quadrants 1

Ameloblastoma

• Well-demarcated borders: 59.2% present as unilocular with well-defined margins 4
• Multilocular appearance: 14 of 71 cases showed multilocular pattern, 2 showed soap-bubble appearance 4
• Slow expansion: Cortical thinning and expansion rather than destruction
• Intact lamina dura: Typically preserved unless directly involved
• Mandibular predilection: 87.3% located in mandible 4

Histopathologic Features

Burkitt Lymphoma

• Morphology:

  • Intermediate-sized lymphoid cells (similar to histiocyte nucleus size) 2
  • Round nuclei with coarse chromatin and multiple small nucleoli 2
  • Scant cytoplasm with clear cytoplasmic vacuoles on Wright-Giemsa stain 2
  • "Starry sky" pattern: Scattered tingible-body macrophages with apoptotic debris indicating high cell turnover 2
  • Patternless sheets of lymphoid cells with pseudo-cohesion 2

• Immunophenotyping:

  • CD20+ (B-cell marker) 2
  • CD10+ (germinal center marker) 2
  • BCL2 negative 2
  • BCL6 positive 2
  • Ki-67 ≥95%: This extremely high proliferation index is virtually diagnostic 2
  • Terminal deoxynucleotidyl transferase negative 2
  • CD3 negative (excludes T-cell origin) 2

• Cytogenetics:

  • MYC translocation involving immunoglobulin gene (typically t(8;14)) 2
  • Simple karyotype with MYC rearrangement as sole abnormality 2

Ameloblastoma

• Morphology:

  • Epithelial tumor with follicular or plexiform patterns 4
  • Peripheral columnar cells with reverse nuclear polarity
  • Central stellate reticulum-like areas
  • No inflammatory infiltrate or tingible-body macrophages
  • May develop within a cyst (16 cases in the study) 4

• Immunophenotyping:

  • Epithelial markers positive (cytokeratin)
  • No lymphoid markers
  • Low Ki-67 proliferation index (typically <10%)

Critical Diagnostic Algorithm

Step 1: Assess tempo of disease

• Days to weeks = Burkitt lymphoma
• Months to years = Ameloblastoma

Step 2: Evaluate radiographic lamina dura

• Loss of lamina dura = Burkitt lymphoma 5
• Preserved lamina dura = Ameloblastoma

Step 3: Check for systemic involvement

• Fever, weight loss, lymphadenopathy = Burkitt lymphoma 2
• Purely local disease = Ameloblastoma

Step 4: Obtain biopsy with specific testing

• Request Ki-67 staining: ≥95% confirms Burkitt lymphoma 2
• Request MYC FISH: Translocation confirms Burkitt lymphoma 2
• Fresh tissue in saline for flow cytometry if Burkitt suspected 2

Common Pitfalls

Do not delay biopsy in suspected Burkitt lymphoma—this is a medical emergency requiring immediate diagnosis and treatment 2. The NCCN guidelines emphasize that morphology and flow cytometry are minimum requirements to begin treatment if the patient is very sick 2.

Do not rely solely on clinical appearance: While ameloblastoma typically presents with slow growth, Burkitt lymphoma can initially present without clinically detectable jaw tumors but with radiographic bone destruction 1.

Jaw radiographs are mandatory when Burkitt lymphoma is suspected, as lamina dura effacement reinforces the diagnosis even in abdominal presentations 5.

Long-term follow-up is essential for ameloblastoma due to 21.1% recurrence rate, with average recurrence age of 26.4 years 4. However, this is irrelevant if the diagnosis is Burkitt lymphoma, which requires immediate intensive chemotherapy 2.

The age of 14 years strongly favors Burkitt lymphoma in the differential diagnosis, as this falls within the peak pediatric incidence, whereas ameloblastoma typically presents in the third decade 2, 4.